Weill Cornell Medicine-New York Presbyterian Hospital is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Weill Cornell Medicine-New York Presbyterian Hospital has participated in 9 clinical trials with 7 currently active.
Therapeutic areas: Myelodysplastic Syndromes, Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency.
Sponsors: Gilead Sciences, Edwards Lifesciences, Cardiac Implants LLC.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Weill Cornell Medicine-New York Presbyterian Hospital has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Weill Cornell Medicine-New York Presbyterian Hospital has 9 clinical trials on record, with 7 currently active. Their work covers Myelodysplastic Syndromes, Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency.
Yes — Weill Cornell Medicine-New York Presbyterian Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.